Picture Demy-Colton BioFuture 2023 NYC Hand 650x100px

News > All

Total search results: 7354 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 72 73 74  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Evotec SE. (7/11/23). "Press Release: Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership". Hamburg. 2023-07-11
Biosynth AG. (7/11/23). "Press Release: Biosynth Expands Capabilities with Acquisition of Celares, Experts in Bioconjugation and Specialty Polymers". Staad. 2023-07-11
Crossbow Therapeutics, Inc-. (7/11/23). "Press Release: Crossbow Therapeutics Launches with $80 Million in Series A Financing to Advance a Novel Class of Antibody Therapies that Mimic T-Cell Receptors to Treat Cancer". Cambridge, MA. 2023-07-11
ECBF Management GmbH. (7/11/23). "Press Release: Aphea.Bio, a Portfolio Company of VC Fund ECBF, Raises a Groundbreaking Series C Round of 70 Million Euros". Luxembourg. 2023-07-11
Ramarketing & PR Ltd.. (7/11/23). "Press Release: Ramarketing Announces North American Expansion". 2023-07-11
Abivax S.A.. (7/11/23). "Press Release: Abivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors". Paris. 2023-07-11
Nanobiotix S.A.. (7/10/23). "Press Release: Nanobiotix Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3". Paris & Cambridge, MA. 2023-07-10
Flash Therapeutics S.A.S.. (7/6/23). "Press Release: Flash Therapeutics Appoints Jérôme Bédier as Président to Accelerate Its Biopharmaceutical CDMO Business Development". Toulouse. 2023-07-06
Numaferm GmbH. (7/6/23). "Press Release: Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides". 2023-07-06
AiCuris Anti-infective Cures AG. (7/6/23). "Press Release: AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients". Wuppertal. 2023-07-06
Cellbox Solutions GmbH. (7/5/23). "Press Release: Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program". 2023-07-05
Camena Bioscience Ltd.. (7/3/23). "Press Release: Camena Bioscience Close $10 Series A Financing as Demand for DNA Synthesis Technology Increases". 2023-07-03
Gamma Biosciences. (6/30/23). "Press Release: Univercells Technologies Acquired by Donaldson Company". Menlo Park, CA. 2023-06-30
Mainz Biomed N.V.. (6/29/23). "Press Release: Mainz Biomed Secures up to $50M in New Funding". Berkeley, CA. 2023-06-29
Heidelberg Pharma AG. (6/29/23). "Press Release: Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics (ad hoc announcement)". Ladenburg. 2023-06-29
BioNTech SE. (6/29/23). "Press Release: BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC". Mainz & Rockville, MD. 2023-06-29
Donaldson Company, Inc.. (6/29/23). "Press Release: Donaldson Acquires Univercells Technologies, Broadens Life Sciences Reach". Minneapolis, MN. 2023-06-29
Eli Lilly and Company. (6/29/23). "Press Release: Lilly to Acquire Sigilon Therapeutics". Indianapolis, IN & Cambridge, MA. 2023-06-29
Gleamer S.A.S.. (6/28/23). "Press Release: Gleamer Raises €27 Million in Series B Funding Round to Expand Its AI Solutions Portfolio and Speed up International Expansion". Paris. 2023-06-28
Synthego Corporation. (6/28/23). "Press Release: Synthego and ATCC Enter Alliance for Cutting-Edge Gene Editing of Mammalian and Mouse Cell Lines". Redwood City, CA. 2023-06-28
MoonLake Immunotherapeutics AG. (6/28/23). "Press Release: MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares". Zug. 2023-06-28
EBD Group. (6/27/23). "Press Release: BIO-Europe 2024 Is Going to Stockholm". Munich. 2023-06-27
Centogene N.V.. (6/27/23). "Press Release: Centogene and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE 2023-06-27
Astraveus S.A.S.. (6/27/23). "Press Release: Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of Its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform". Paris. 2023-06-27
AC Immune S.A.. (6/27/23). "Press Release: AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease". Lausanne. 2023-06-27
EBAMed S.A.. (6/27/23). "Press Release: EBAMed, Swiss-Italian Company, Raises EUR 14.35 Million in Series A Funding to Develop Its Novel Image Guidance System for the Non-invasive Treatment of Ventricular Tachycardia through Proton Therapy". Zug. 2023-06-27
Helmholtz-Zentrum für Infektionsforschung (HZI. (6/27/23). "Press Release: Geneticist Josef Penninger Becomes New Scientific Director of the Helmholtz Centre for Infection Research". 2023-06-27
MoonLake Immunotherapeutics AG. (6/26/23). "Press Release: MoonLake Immunotherapeutics Announces Proposed Underwritten Public Offering". Zug. 2023-06-26
MoonLake Immunotherapeutics AG. (6/25/23). "Press Release: MoonLake Immunotherapeutics Achieves Landmark Milestone with Positive Phase 2 Results for Nanobody Sonelokimab in Hidradenitis Suppurativa". Zug. 2023-06-25
Bicycle Therapeutics plc. (6/23/23). "Press Release: Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer". Cambridge & Boston, MA. 2023-06-23
Abcam plc. (6/23/23). "Press Release: Abcam Announces Review of Strategic Alternatives". Cambridge & Waltham, MA. 2023-06-23
Lunaphore Technologies S.A.. (6/22/23). "Press Release: Lunaphore to Get Acquired by Bio-Techne". Tolochenaz & Minneapolis, MN. 2023-06-22
Memo Therapeutics AG. (6/22/23). "Press Release: Memo Therapeutics AG Starts U.S. Pivotal Phase II/III Clinical Trial with AntiBKV for Treatment of BKV Infection in Renal Transplant Patients". Schlieren. 2023-06-22
SandboxAQ. (6/22/23). "Press Release: SandboxAQ Announces Biopharma Molecular Simulation Division to Speed Life-Saving Drugs to Patients Through AI and Quantum Solutions". Palo Alto, CA. 2023-06-22
SareptaTherapeutics, Inc.. (6/22/23). "Press Release: Sarepta Therapeutics Announces FDA Approval of ELEVIDYS, the First Gene Therapy to Treat Duchenne Muscular Dystrophy". Cambridge, MA. 2023-06-22
Tagworks Pharmaceuticals B.V.. (6/22/23). "Press Release: Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics". Nijmegen & Boston, MA. 2023-06-22
Pieris Pharmaceuticals, Inc.. (6/21/23). "Press Release: Pieris Pharmaceuticals Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study". Boston, MA. 2023-06-21
MaaT Pharma. (6/21/23). "Press Release: MaaT Pharma Announces New Appointments to the Board and Executive Team". Lyon. 2023-06-21
Delve Bio. (8/20/23). "Press Release: Delve Bio Launches to Commercialize its Metagenomic Sequencing Platform for Infectious Disease Diagnosis". San Francisco, CA. 2023-06-20
Upstream Bio (US). (6/20/23). "Press Release: Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases". Allschwil. 2023-06-20
Thermosome GmbH. (6/20/23). "Press Release: Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment". Munich. 2023-06-20
Eli Lilly and Company. (8/20/23). "Press Release: Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology". San Francisco, CA. 2023-06-20
Galapagos N.V.. (6/15/23). "Press Release: Galapagos Appoints Thad Huston as Chief Financial Officer and Chief Operating Officer". Mechelen. 2023-06-15
Mainz Biomed N.V.. (6/15/23). "Press Release: Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference". Mechelen. 2023-06-15
Theradaptive, Inc.. (6/15/23). "Press Release: Theradaptive Closes $26 Million Series A Investment Round". Frederick, MD. 2023-06-15
Centogene N.V.. (6/14/23). "Press Release: Centogene Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency". Cambirdge, MA, Rostock & Berlin. 2023-06-14
CRISPR Therapeutics AG. (6/13/23). "Pressemitteilung: CRISPR Therapeutics to Participate in Goldman Sachs 44th Annual Global Healthcare Conference". Zug & Cambridge, MA. 2023-06-13
Qiagen N.V.. (6/13/23). "Press Release: Danish National Genome Center Selects Qiagen for Variant Interpretation in Oncology Genome Sequencing". Venlo & Redwood City, CA. 2023-06-13
Agilent Technologies Inc.. (6/12/23). "Press Release: Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference". Santa Clara, CA. 2023-06-12
Beacon Therapeutics Holdings Ltd.. (6/12/23). "Press Release: Beacon Therapeutics Launches with £96 Million ($120 Million) to Develop a New Generation of Gene Therapies for Retinal Diseases Resulting in Blindness". London & Oxford. 2023-06-12
Galapagos N.V.. (6/12/23). "Pressemitteilung: Galapagos Appoints Dr. Susanne Schaffert as Non-executive Independent Director to Its Board". Mechelen. 2023-06-12
Novartis AG. (6/12/23). "Pressemitteilung: Novartis Bolsters Innovative Medicines Strategy and Renal Pipeline with Agreement to Acquire Chinook Therapeutics for USD 3.2bn Upfront (USD 40 / Share)". Basel. 2023-06-12
Illumina, Inc.. (6/11/23). "Press Release: Illumina Announces CEO Transition Plan". San Diego, CA. 2023-06-11
Digital Science. (6/7/23). "Press Release: Digital Science Boosts Pharma Industry Support Following OntoChem Acquisition". London & Halle (Saale). 2023-06-07
AAVantgarde Bio S.r.l.. (6/6/23). "Press Release: AAVantgarde Closes €61 Million Series A Financing to Advance Two Therapeutic Programs into the Clinic". Milan. 2023-06-06
Abzena Ltd.. (6/6/23). "Press Release: Abzena Appoints Thomas Castellano as Chief Financial Officer". San Diego, CA. 2023-06-06
Gilde Healthcare Partners. (6/5/23). "Press Release: Gilde Healthcare Strengthens US Venture&Growth Team with Rich Wilmot as Partner". Garching. 2023-06-05
BiondVax Pharmaceuticals Ltd.. (6/5/23). "Press Release: BiondVax Signs Exclusive License Agreement for Development and Commercialization of a Novel anti-IL-17 Antibody". Jerusalem. 2023-06-05
ITM Isotope Technologies Munich SE. (6/5/23). "Press Release: ITM Announces €255m Investment Round, Plans to Advance Radiopharmaceutical Pipeline and to Expand Radioisotope Production Capacities". Garching. 2023-06-05
Waters Corporation. (6/5/23). "Press Release: Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing". Milford, MA & Göttingen. 2023-06-05
Bayer AG. (6/5/23). "Press Release: Bayer Strengthens Gene Therapy Portfolio with Lipid Nanoparticle Technology from Acuitas Therapeutics [Not intended for U.S. and UK Media]". Berlin. 2023-06-05
Bruker Corporation. (6/2/23). "Press Release: Bruker Corporation to Present at Jefferies 2023 Healthcare Conference". Billerica, MA. 2023-06-02
BC Platforms AG. (6/1/23). "Press Release: BC Platforms Acquires 4Pharma, a Leading International Provider of Medical Research Data and Analytics Services for Global Clinical Trials and Real World Data". Zurich. 2023-06-01
Ariceum Therapeutics GmbH. (6/1/23). "Press Release: Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics Ltd". Berlin. 2023-06-01
Boundless Bio, Inc.. (6/1/23). "Press Release: Boundless Bio to Present at the 2023 Jefferies Healthcare Conference". San Diego, CA. 2023-06-01
IO Biotech, Inc.. (6/1/23). "Press Release: IO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior Vice President, Commercial and Program Lead". New York, NY. 2023-06-01
Sophia Genetics S.A.. (5/31/23). "Press Release: Sophia Genetics Announces Nomination of Lila Tretikov to Board of Directors". Boston, MA & Lausanne. 2023-05-31
eXmoor Pharma Concepts Ltd.. (5/30/23). "Press Release: eXmoor Pharma Completes $35 Million Series A to Expand Cell and Gene Therapy Manufacturing Capabilities". Bristol. 2023-05-30
GreenLight Biosciences, Inc.. (5/30/23). "Press Release: GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction". Lexington, MA. 2023-05-30
Mithra Pharmaceuticals S.A.. (5/29/23). "Press Release: Mithra Appoints Experienced Life Sciences Executive Christian Homsy as Chairman". Liège. 2023-05-29
BenevolentAI. (5/25/23). "Press Release: BenevolentAI Unveils Strategic Plan to Position the Company for a New Era in AI". London. 2023-05-25
ElevateBio, LLC. (5/24/23). "Press Release: ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth". Waltham, MA. 2023-05-24
Renegade Therapeutics, Inc.. (5/23/23). "Press Release: ReNAgade Therapeutics Launches with Over $300 Million in Series A Financing to Unlock the Limitless Potential of RNA Medicine". Cambridge, MA. 2023-05-23
AvroBio, Inc.. (5/22/23). "Press Release: AvroBio Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million". Cambridge, MA. 2023-05-22
VectivBio AG. (5/22/23). "Press Release: Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases". Boston, MA & Basel. 2023-05-22
Freenome, Inc.. (5/22/23). "Press Release: Freenome Acquires Global Immunodiagnostics Developer Oncimmune Ltd". South San Francisco, CA. 2023-05-22
CureVac N.V.. (5/19/23). "Press Release: CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech". Tübingen. 2023-05-19
Alltrna. (5/18/23). "Press Release: Alltrna Engineers tRNA Oligonucleotide with Improved Potency and Activity for In Vivo Readthrough of Premature Termination Codons". Cambridge, MA. 2023-05-18
Synthego Corporation. (5/17/23). "Press Release: Synthego Announces Invalidation of Agilent Patents in CRISPR Dispute". Redwood City, CA. 2023-05-17
NewLimit Inc. [Armstrong, Brian, et al.]. (5/16/23). "Press Release: NewLimit Secures $40 Million in Venture Funding from Dimension Capital, Founders Fund, Kleiner Perkins and Other Investors [Blog Post]". 2023-05-16
Boundless Bio, Inc.. (5/16/23). "Press Release: Boundless Bio Announces $100 Million Oversubscribed Series C Financing Co-led by Leaps by Bayer and RA Capital Management". San Diego, CA. 2023-05-16
Waters Corporation. (5/16/23). "Press Release: Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology". Milford, MA. 2023-05-16
H.E.L. Group. (5/16/23). "Press Release: H.E.L Group Makes Senior Appointments as It Continues to Scale Globally". London. 2023-05-16
Nido Biosciences, Inc.. (5/15/23). "Press Release: Nido Biosciences Emerges as Clinical Stage Company Raising $109 Million to Advance Treatments for Debilitating Neurological Diseases". Watertown, MA. 2023-05-15
Exazyme GmbH. (5/15/23). "Pressemitteilung: Exazyme sichert sich 2 Mio. Euro Finanzierung für KI-gestützte Proteinentwicklung". Berlin. 2023-05-15
Qiagen N.V.. (5/15/23). "Press Release: Qiagen Expands Enzyme Offering to Support Individual Life Science Research Labs Worldwide". Berlin. 2023-05-15
Uniqure N.V.. (5/15/23). "Press Release: Uniqure Announces Sale of Royalty Interest in Hemgenix for up to $400 Million". Lexington, MA & Amsterdam. 2023-05-15
Evotec SE. (5/12/23). "Press Release: Evotec Publishes Annual Report 2022 and Quarterly Statement for Q1 2023". Hamburg. 2023-05-12
Vivlion GmbH. (5/11/23). "Press Release: Vivlion to Provide Services to Repare Therapeutics on Advanced PRCISR CRISPR gRNA Libraries". Frankfurt. 2023-05-11
Synthego Corporation. (5/11/23). "Press Release: Synthego Opens State-of-the-Art GMP Guide RNA Manufacturing Facility to Enable CRISPR Genomic Medicines". Redwood City, CA. 2023-05-11
Bicycle Therapeutics plc. (5/10/23). "Press Release: Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology". Berlin, Cambridge & Boston, MA. 2023-05-10
DiogenX S.A.S.. (5/10/23). "Press Release: DiogenX Raises €27.5M Series A Financing to Advance Its First-in-Class Regenerative Treatment for Type 1 Diabetes Towards Clinical Development". Marseille. 2023-05-10
Scailyte AG. (5/9/23). "Press Release: Jan Lichtenberg Joins Scailyte’s Board of Directors". 2023-05-09
Evotec SE. (5/9/23). "Press Release: Just – Evotec Biologics Launches Tech Partnership for Biosimilars Development and Commercial Manufacturing". Hamburg & Seattle, WA. 2023-05-09
Ascend Gene and Cell Therapies Ltd.. (5/9/23). "Press Release: Gene and Cell Therapy Manufacturing Specialist Ascend Launches with over $130M of Funding as Expert Teams Merge". London. 2023-05-09
Biosynth AG. (5/9/23). "Press Release: Biosynth Further Strengthens Peptide Business with Acquisition of Cambridge Research Biochemicals". Staad. 2023-05-09
Ginkgo Bioworks Inc.. (5/8/23). "Press Release: Ginkgo Bioworks Partners with Boehringer Ingelheim to Develop Breakthrough Therapies for Hard-to-Treat Diseases". Boston, MA. 2023-05-08
Bruker Corporation. (5/8/23). "Press Release: Bruker Announces Acquisition of Zontal to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions". Billerica, MA. 2023-05-08
Bionter AG. (5/8/23). "Press Release: Bionter Announces Partnership Agreement with Midwest Biosolutions to Drive Market Growth in the US". Basel. 2023-05-08
Alia Therapeutics S.r.l.. (5/5/23). "Press Release: Alia Therapeutics Names Letizia Goretti as Chief Executive Officer". Milan. 2023-05-05
next pagenext page 1 2 3 ... 72 73 74  next pagenext page


Picture Demy-Colton BioFuture 2023 NYC View 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2023 NYC Industry Leaders 650x300px

» top